GLP1R and type 2 diabetes mellitus: Recent pharmacological interventions, such as glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors (SGLT2i), can facilitate clinically relevant weight loss in individuals with type 2 diabetes [83,84,85].